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Abstract
Background: Unsweetened natural cocoa has antimalarial properties. Unsweetened natural cocoa powder (UNCP),
obtained as a result of the removal of cocoa butter from a cocoa bean protects against malaria episodes. Cocoa
powder, which is prepared after removal of the cocoa butter, contains about 1.9 % theobromine and 0.21 %
caffeine. Concomitant consumption of cocoa and artemether/lumefantrine (A/L) is a common practice in Ghana,
West Africa. This study seeks to determine the elemental composition of UNCP and its protective effect on the
heart and kidney against (A/L) administration.
Methods: Energy dispersive x-ray fluorescence spectroscopy was used to detect the quality and quantity of the
elemental composition in UNCP. Thereafter, 30 nonmalarious male guinea pigs were divided into five groups of six
animals each. One group was administered with 75 mg/kg body weight A/L only and another group distilled water
(control group). The rest received 300 mg/kg, 900 mg/kg and 1500 mg/kg body weight UNCP for 14 days orally
and A/L for the last 3 days (ie day 11 to day 14). Biochemical and histopathological examinations were carried out
after euthanisation of the animals.
Results: A total of thirty-eight (38) micro and macro elements were detected with the ED-XRF. Macro elements like
sodium (Na), magnesium (Mg), aluminium (Al), phosphorus (P), chlorine (Cl), potassium (K), calcium (Ca), manganese
(Mn) and iron (Fe) and micro elements like chromium (Cr), copper (Cu), zinc (Zn), arsenic (As), and lead (Pb) were
identified and evaluated. Biochemical analysis revealed increases in HDL levels (p>0.05) while there were decreases
in LDL levels (p>0.05), creatine kinase and AST levels (P<0.05) in animals that received UNCP compared to A/L only
administered group. Urea levels reduced significantly by 53 % (p<0.05) in group that received 1500 mg/kg UNCP.
Histopathological examinations of the heart and kidney buttressed the protective effects of cocoa administration.
Conclusion: The percentage of recommended daily allowance of UNCP for chromium is 3750 % for men and 5250 %
for women while % RDA for copper corresponds to 103.6 % in both sexes. UNCP proved to possess cardioprotective
and renoprotective potential during artemether-lumefantrine administration.
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Glomerular Degeneration; HDL, High density lipoprotein; LD, Low dose; LD50, Lethal dose; LDL, Low density lipoprotein;
MRCI, Minimal red blood cell infiltration; NCG, Negative Control Group; NG, Normal glomeruli; NNL, Normal nuclear
lining; NO, Nitric oxide; RDA, Recommended daily allowance; S-D, Sprague-Dawley; SDR, Sprague-Dawley Rats;
TC, Tubular Congestion/ obliterated proximal convoluted tubular lumen; TG, Triglycerides; TLA, Tubular lining
anucleasis; UNCP, Unsweetened natural cocoa powder; UTL, Uncongested tubular lumen; VCG, Vehicle Control Group;
VLDL, Very low density lipoproteins
Background
Artemether-lumefantrine (A/L) is one of the approved
fixed-dose artemisinin-based combination therapies (ACTs)
that serves as the drug of choice for treatment of uncom-
plicated malaria in Ghana. It is commonly dispensed as an
over-the-counter drug. Current trend of research is geared
towards increasing the dose currently in use to prevent
drug resistance [1]. A/L administration, however, generates
free radicals that has the potential of causing cellular dam-
age with evidence of both cardiotoxic, renal toxicity and
other organ toxicity [1, 2]. The toxic potentials of A/L have
been well reported in both humans [1, 2] and animal exper-
iments using guinea-pigs [3–5].
While cardiovascular and renal diseases deaths account
for more than 75 % in low and middle-income countries,
attempts are being made to use natural products and life
styles to help curb this menace [6, 7].
Cocoa, a regular diet in Ghana, and which contributes
about 28 % to Ghana’s foreign exchange is known to play a
major role in cardiovascular and renal health [7, 8]. Its use
is often limited by the presence of heavy metals [9, 10].
The chemical components of cocoa have been well investi-
gated using various methods [11–13]. Cocoa powder,
which is prepared after removal of the cocoa butter,
contains about 1.9 % theobromine and 0.21 % caffeine
[14]. Most natural cocoa powder in Ghana is sweet-
ened. The polyphenols of unsweetened natural cocoa
powder (UNCP) have proven to be very vital sources
of antioxidants [2]. Regular intake of unsweetened nat-
ural cocoa powder as a beverage has immense health
benefits including both cardiovascular and neurode-
generative disorders, reduces platelet aggregation and
improves lipid profile [9, 15, 17]. There have been re-
ports on cocoa being used as diet mediated malaria
prophylaxis, where regular intake of cocoa powder as a
beverage has been associated with reduction in the in-
cidence of episodic malaria [18]. Research has also
confirmed the potential antiplasmodial activity of dif-
ferent fractions especially the non-polar solvent frac-
tions (chloroform, ethylacetate and petroleum ether)
of cocoa. Thus UNCP has measurable direct in vitro
inhibitory effect on P. falciparum and support the an-
ecdotal reports of its ability to prevent malaria as a
result of its regular intake as a beverage [19, 20]. Ir-
respective of its many advantages, very high levels of
cocoa intake could be deleterious to health, an effect be-
lieved to be caused by (−) epigallocatechin-3-gallate, a
component of polyphenols in cocoa that act as pro-
oxidant and is also cytotoxic to cells [21–23]. Simultan-
eous consumption of cocoa beverage during antimalarial
treatment with A/L is expected to have dual benefits such
as rapid clearance of the malaria parasites as well as ameli-
oration of A/L-induced toxic injury to heart and kidneys.
The use of natural antioxidants such as found in cocoa
could be beneficial in rectifying such damage in humans
[16]. Therefore, cocoa and its products come in handy
in the search for natural remedies that may offer cardio-
vascular and renal protective effects against high dose
A/L induced organ toxicity.
This study determines the major elemental composition
of significant relevance in cardiovascular and renal disor-
ders, biochemical and histopathological changes that occur
during A/L administration following prophylactic treat-
ment with UNCP in experimental animals. The study also
aimed at assessing whether UNCP will worsen or is able to
prevent some common cardiovascular and renal side
effects associated with the use of A/L.
Methods
Preparation of UNCP solution
Calculated amount (9.6 g) of Brown Gold Natural
Cocoa Powder from Hords Company Ltd, (Batch num-
ber BT620IT) registered with the Ghana Food and
Drugs Authority (FDA/DK06-070) was dissolved in
warm distilled water (40 ml) with stirring making a
concentration of 240 mg/ml (of the UNCP). The prep-
aration was then administered to the animals via oral
gavage based on their individual body weights. Fresh
sample of cocoa powder extract was prepared daily for
administration.
Phytochemical analysis
Phytochemical analysis was conducted to determine the
various constituents in the UNCP according to Harborne
[24]. A fresh sample of UNCP was prepared each day of
administration by dissolving 1 g in 1 mL de-ionized water.
Saponin test
About 0.5 g of UNCP was added to water in a test tube.
The test tube was shaken to observe foam formation.
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Tannins test
About 0.5 g of UNCP was dissolved in 80 % of aqueous
methanol (10 cm3). Freshly prepared iron (III) chloride
solution was added and colour change was observed.
Alkaloid test
About 0.1 g of the UNCP was added to 2 M HCl, stirred,
warmed and filtered. The filtrate was divided into three
test tubes. Draggendorff ’s reagent, Mayer’s reagent and
Wagner’s reagent were added, respectively, to each test
tube. The colourations were observed.
Flavanoids test
About 0.1 g of UNCP was added to 80 % ethanol
(15 cm3). To the filtrate was added magnesium turnings
followed by concentrated HCl (0.5 cm3), and observed
for colour changes within 10 min.
Cardiac glycoside test
About 0.5 g of UNCP was dissolved in chloroform
(2 cm3) in a test tube after which concentrated sulphuric
acid was carefully added down the side of the test tube
to form a lower layer.
Energy dispersive macro and micro element measurements
The UNCP was sieved using sieve of 180 μm. Energy
dispersive X-ray (ED XRF) was used for simultaneous
analysis and measurement of the elemental content of
the UNCP. Spectro x-lab 2000 spectrometer enhanced
with three-axial geometry to reduced background noise
due to radiation polarization. The monochromatic radia-
tions emitted from the X-ray tube were applied to excite
the atoms of the sample. This spectrometer is equipped
with Rh anode small detector and 400w Pd x-ray tube,
Be end window, a Si (Li) detector, an HOPG (high ori-
ented pyrolitic graphite) as a BARKLA polarizer (Al, Mo
and Co) as secondary target. Combination of these dif-
ferent targets gave a typical detection limit for eight ele-
ments (Si, Al, Mg and Na) in the range of 25–50 ppm
and 1–5 ppm for heavy metals. The spectrometer is fac-
tory calibrated using a number of internationally recog-
nized standards [25, 26]. Besides, the Recommended
Daily Allowance (RDA) of each element as provided by
literature and WHO was also noted and percentage %
RDA noted [27, 28].
Experimental animals and Husbandry
Thirty (30) non-malarious male guinea pigs weighing
300 g–450 g were obtained from the Noguchi Memorial
Institute for Medical Research, University of Ghana,
Legon and divided into 5 groups of 6 animals randomly
selected. The animals were allowed to acclimatize for 1
week in a well-ventilated room, maintained at a room
temperature of 22.00 ± 1.00 °C and relative humidity of
60 ± 1 % and exposed to a natural daily photoperiodicity
of 12 h light-dark cycle. The guinea pigs were provided
with autoclaved sankofa goat and sheep pellet diet from
Ghana Agro Food Company (GHAFCO), standard ro-
dent feeds and water ad libitum. Spontaneous behaviors
of all guinea pigs were observed in cages before experi-
mental procedures were carried out. Animals used in
this study were handled in accordance with the inter-
national guidelines for Care and Use of Laboratory Ani-
mals [29]. No animals showed signs of illness before the
experiments. The study protocol was approved by the
departmental ethical and protocol review committee and
the Noguchi Memorial Institute for Medical Research
Institutional Animal Care and Use Committee with
protocol approval number 2013-01-3E.
Preparation of A/L solution
A concentration of 20 mg/ml of artemether/lumefan-
trine (or coartem®) from Novartis Company Ltd (with
reference to artemether), was prepared and administered
to the guinea pigs in the UNCP treated groups at a dose
of 75 mg/kg body weight daily for 3 days via oral gavage.
This was done according to Osonuga, et al. [30] and
Aprioku, 2012 [31]. Dosage was calculated with reference
to the dose of artemether in the drug combination. To
achieve this, seventy (70) tablets of Novartis coartem®
dispersible tablets (20/120 mg) which is equivalent to
1400 mg of artemether, was dissolved in 70 ml of distilled
water and stirred until completely homogenous.
Administration of drugs
Guinea pigs were divided into 5 groups of 5 animals each.
Group I-Vehicle control ‘CTRL’ (distilled water for
14 days).
Group II-Negative control ‘COART’ (75 mg/kg A/L
only last 3 days).
Group III-300 mg/kg UNCP (14 days) + A/L 75 mg/kg
(12th–14th day).
Group IV-900 mg/kg UNCP (14 days) + A/L 75 mg/kg
(12th–14th day).
Group V-1500 mg/kg UNCP (14 days) + A/L 75 mg/kg
(12th–14th day).
During the first 14 days of dosing, animals in
groups III, IV, and V were administered prophylactic
doses of the cocoa powder at 300 mg/kg, 900 mg/kg
and 1500 mg/kg body weight respectively, as used in
other studies [14] for 14 days against A/L administra-
tion. Animals in group I were given distilled water ie
vehicle control group (VCG) for 14 days with group
II receiving 75 mg/ kg A/L ie negative control group
(NCG) for the last 3 days within the 14 day period.
Drugs were administered by oral gavage. The weights
of the animals were taken weekly and the doses ad-
ministered adjusted accordingly.
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In all cases, fresh solutions of UNCP and A/L were
prepared before each dosing. The present study was
performed according to international rules considering
animal experiments.
Biochemical assays
Animals were sacrificed after 14 days of drug treatments.
Blood samples were collected into plain gel tubes,
allowed to clot, centrifuged for 15 min at 3,000 rpm and
sera removed and stored at-20 °C until used. Sera
obtained were assayed for biochemical parameters,
namely, total cholesterol, triglycerides, high density li-
poproteins (HDL), low density lipoproteins (LDL),
very low density lipoproteins (VLDL), creatine kinase
(CK) and aspartate transferase, creatinine, urea and
blood electrolytes [30, 31]. These were measured
using the Selectra Junior Autoanalyser (Vital Scientific
BV, Version 04, Netherlands).
Histopathology
Euthanized guinea pigs were dissected and their hearts
and kidneys were removed. The tissues were preserved
in 10 % buffered formalin. The tissues were embedded
in paraffin wax, sectioned at 4 μm thickness and stained
with hematoxylin-eosin. Histological slides of the study
animals were evaluated alongside those from the two
controls groups using a light microscope. For each group
of guinea pigs, a total of 30 photomicrographs were
taken at magnification of × 40.
Data analysis
Results were expressed as mean ± SEM. Data was ana-
lysed using one-way analysis of variance, followed by
Newman-Keuls multiple comparison test. Values of
p 0.05 were considered statistically significant. Dunnet
Multiple Comparison Test was used in the analysis of
the nitric oxide levels.
Results
Phytochemical analysis
Phytochemical analysis of unsweetened natural cocoa
powder showed the presence of saponins, alkaloids, fla-
vonoids and cardiac glycosides.
Macro and micro element analysis
In using UNCP as a beverage, general recommendation
is 2–3 teaspoonful of the powder to be stirred in hot
water. A teaspoon corresponds to almost five grammes
(5 g). Thus Two (2) or three (3) teaspoonful comes to 10
or 15 g respectively, averaging 12.5 g of UNCP.
Comparing these values to the Recommended Daily
Allowance (RDA) of each element, the estimated per-
centage of RDA as supplied by UNCP to consumers is
determined.
The level of elements in UNCP extrapolated to litera-
ture RDA values (ie % RDA of UNCP) in both men and
women are as shown in the table below.
Biochemical assays
Lipid profile
Generally, there was little change in the mean levels of
cholesterol in animals in the VCG, NCG (1.242 ±
0.170 mmol/L) and those that received UNCP 300 mg/kg
cocoa + A/L (1.374 ± 0.381 mmol/L), 900 mg/kg cocoa +
A/L (1.380 ± 0.172 mmol/L) and 1500 mg/kg cocoa + A/L
(1.388 ± 0.242 mmol/L) compared to the VCG (1.290 ±
0.119 mmol/L) (P < 0.05) (Fig. 1).
The mean serum levels of low density lipoprotein
(LDL) decreased in the medium and high UNCP dose
groups by 11.6 and 10.6 % (p < 0.05), respectively com-
pared to the NCG (0.662 ± 0.269 mmol/L) (Fig. 2).
Serum levels of both VLDL (Fig. 3) and triglycerides
increased as the dose of administered UNCP increased.
Triglyceride changes were as follows: controls (1.075 ±
0.360 mmol/L), A/L administered group (0.966 ±
0.619 mmol/L), 300 mg/kg UNCP (0.980 ± 0.391 mmol/
L), 900 mg/kg UNCP (1.208 ± 0.317 mmol/L), 1500 mg/
kg UNCP (1.478 ± 0.487 mmol/L) (P < 0.05) (Fig. 4).
With regard to the mean serum levels of high density
lipoprotein (HDL), there was a 12.9 % (P < 0.05) increase
in the group that received 900 mg/kg UNCP compared
to the NCG 0.148 ± 0.046, (P < 0.05), (Fig. 5).
The levels of coronary risk was high (11.778 ± 1.167)
in animals that received 1500 mg/kg UNCP and low
(8.470 ± 2.624) in the animals that received 900 mg/kg
UNCP compared to the NCG (9.08 ± 2.894, P < 0.05)
(Fig. 6).
AST levels The mean serum levels of AST in the 300 mg/
kg, 900 mg/kg and 1500 mg/kg UNCP administered
groups were 140.8 ± 55.65U/L (80.9 %), 182 ± 73.8U/L
Fig. 1 Serum cholesterol (mmol/L) concentration of male guinea
pigs administered different prophylactic doses of UNCP. Values
are expressed as mean ± SEM (n = 6). P values < 0.05 were
considered significant
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(75.3 %), 266.6 ± 321.0U/L (63.9 %) respectively compared
to the A/L administered group (737.6 ± 100U/L) (Fig. 7).
Creatine kinase The mean levels of CK in VCG (598.0
± 382.425 μmol/L), NCG (1039.0 ± 749.494 μmol/L)
were significantly different. The groups that received
300 mg/kg UNCP), 900 mg/kg UNCP and 1500 mg/kg
UNCP had their CK as follows: 552.2 ± 399.968 μmol/L,
318.5 ± 122.516 μmol/L and 366.8 ± 174.921 μmol/L re-
spectively (Fig. 8). The LD, MD and HD cocoa groups
hence reduced the creatine levels by 46.9, 69.3 and
64.7 % respectively (P < 0.05).
Renal function Test
Urea was reduced by 53 % in 1500 mg/kg when com-
pared to the VCG (P < 0.05). Groups 3 and 4 reduced
urea by 14 and 10.64 % when compared to the VCG
(Fig. 9).
Creatinine level significantly increased by 24.08 % in
NCG compared to VCG. creatinine level decreased by
21.27, 17.54 and 11.05 % in Groups 3, 4 and 5 respect-
ively when compared to group 1 (P < 0.05) (Fig. 10).
Sodium, potassium and chloride levels remained rela-
tively unchanged in all groups as compared to the controls
that received distilled water only.
Histopathological Examination
The figures below show photomicrographs of myocardial
tissues of animals from the different experimental groups.
Sections of cardiac muscle of animals that received A/L
75 mg/kg only showed patchy areas of congestion,
oedema, extensive nuclear and tissue degeneration leading
to loss of microstructure of myocardial tissues. In con-
trast, sections of cardiac muscle of the control group and
animals that received 300 mg/kg UNCP retained the
Fig. 2 Serum LDL (mmol/) levels in male guinea pigs administered
different prophylactic doses of UNCP. Values are expressed as mean ±
SEM (n = 6). P values < 0.05 were considered significant
Fig. 3 Serum VLDL (mmol/l) levels in male guinea pigs administered
different prophylactic doses of UNCP. Values are expressed as mean ±
SEM (n = 6). P values < 0.05 were considered significant
Fig. 4 Serum triglyceride (mmol/L) levels in male guinea pigs
administered different prophylactic doses of UNCP. Values are expressed
as mean ± SEM (n= 6). P values < 0.05 were considered significant
Fig. 5 Serum HDL (mmol/L) levels in male guinea pigs administered
different prophylactic doses of UNCP. Values are expressed as mean ±
SEM (n = 6). P values < 0.05 were considered significant
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normal branching of myocardial cells characteristic of
normal myocardial tissue histology. Similarly, myocardial
tissue sections of animals that received 1500 mg/kg largely
showed normal cardiac tissue histomorphology. There
was very little in terms of deterioration or inflammation to
report. Significantly, there was evidence of ongoing tissue
necrosis in a section of myocardial tissue of one of the ani-
mals that received 900 mg/kg UNCP. There was loss of
cells and nuclei in the region pointed out. In addition, the
region appeared intensely stained indicating the presence
of dead cells.
Discussion
Phytochemicals are extensively studied for the treatment
of different ailments [32–34]. The pharmacological as-
sessment of UNCP was incomplete without evaluation
of its phytochemical profile. Therefore, in this study
UNCP was examined for the presence of different
phytochemicals (flavonoids, tannins, alkaloids, saponins,
terpenoids and glycosides). The above study has shown
that, UNCP contains flavonoids, alkaloids, tannins, sapo-
nins, terpenoids and glycosides which is consistent with
previous findings [34]. These components have been
found to play significant role in enhancing cardiovascu-
lar and renal functions.
Serum levels of total cholesterol, LDL cholesterol and
TG did not change significantly during both A/L and
UNCP administration. It must however be noted that
lipid profile including cholesterol in general takes con-
siderable time to show significant changes even with
cholesterol lowering agents. Thus, the 14-day adminis-
tration of cocoa may not have been long enough to pro-
duce significant changes in serum cholesterol and TG
levels in the experimental animals. The lipid profile
Fig. 6 Coronary risk ratio in male guinea pigs administered different
prophylactic doses of UNCP. Values are expressed as mean ± SEM (n= 6).
P values < 0.05 were considered significant
Fig. 7 Serum aspartate transferase (μ/L) levels in male guinea
pigs administered different prophylactic doses of UNCP. Values
are expressed as mean ± SEM (n = 6). P values < 0.05 were considered
significant
Fig. 8 Serum creatine kinase (μmol/L) levels in male guinea pigs
administered different prophylactic doses of UNCP. Values are
expressed as mean ± SEM (n = 6). P values < 0.05 were considered
significant
Fig. 9 Changes in urea (μmol/L) levels during a 14- day administration
of UNCP in male guinea pigs followed by a 3-day coartem®
administration. Values are expressed as mean ± SEM, n = 6. The
differences among the mean were analyzed using one-way ANOVA
followed by Neuman-keul’s post hoc analysis. Vertical bars represent
Mean ± SEM of Urea levels on various animal groupings. Values are
considered significant when *P < 0.05
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concurs partly with observations from a previous study
that showed that short-term supplementation with cocoa
products was associated with a decrease in LDL choles-
terol, but had no significant effect on total cholesterol
and HDL cholesterol compared with controls, an effect
likely to be dependent on the amount of cocoa being
consumed [35].
Proteins, cholesterol and TG in varying amounts are
important components of lipoproteins of which VLDL
has the highest amount of TG. It was also observed that
serum VLDL levels appeared not to have been signifi-
cantly affected by the administration of UNCP. This
might explain the similarity in the nature of the graphs
for serum TG and VLDL (Figs. 7, 8 and 9).
CK or creatine phosphokinase is a marker of damaged
tissues that are rich in CK. Increases in CK levels are
also most often as a result of myocardial injury [36, 37].
The study showed that animals that received 900 mg/kg
bwt + A/L had 69.3 % reduction in serum CK showing
the greatest mitigating activity against coartem toxicity
(Fig. 1). Since CK is also concerned with the conversion
of creatine to produce phosphocreatine and adenosine
diphosphate, it might also protect or enhance myocar-
dial bioenergetics [36, 37].
Further, we assessed the coronary risk ratio which is
an important indicator of cardiovascular health. Coron-
ary risk ratio in the high dose (1500 mg/kg cocoa + A/L)
group was high compared to the controls (Fig. 10). This
observation agrees with findings that although cocoa
possesses many benefits, intake at very high levels could
be deleterious to health, an effect believed to be caused
by (−) epigallocatechin-3-gallate [21–23].
Aspartate transferase is an enzyme distributed mostly
in the heart followed by the liver and skeletal muscles.
High serum aspartate transferase values are hence indi-
cative of cellular injury and may present in myocardial
disease, shock, hypoxia, among others. Administration
of distilled water + A/L significantly increased the serum
levels of aspartate transferase which were significantly
reduced in all animals administered unsweetened natural
cocoa powder extract. These observations are corrobo-
rated by histopathological examination of the myocardial
tissues of the guinea pigs (Fig. 11a). The results indicate
that tissue sections from animals receiving only A/L
75 mg/kg showed evidence of inflammation and degen-
eration of the myocardial tissue (Fig. 11b), which but-
tresses the biochemical results obtained. Sections of
myocardial tissue of animals administered UNCP extract
largely exhibited normal cardiac tissue structure except
those of animals that received 900 mg/kg UNCP where
there was a single case observed with suspected ongoing
tissue necrosis at the initial stages. Similar observations
of the cardioprotective effect have also been made by
other researchers [36–38].
According to Table 1, the elemental composition of
UNCP showed the presence of sodium, potassium, cal-
cium and magnesium believed to play major roles in the
pathophysiology of cardiovascular disorders [30, 38, 39].
Furthermore, element such as magnesium, zinc, copper,
and chromium are known to be involved in cellular bio-
energetics [36, 37]. Thus the cardioprotective effects of
UNCP may be attributed to the high content of these
elements. Extrapolating animal dosage to humans and
taking into account, the body surface area (BSA), then
the human equivalent dose (HED) of 1500 mg/kg UNCP
corresponds to 324.3 mg/kg HED, which is equivalent to
22701 mg per 70 kg average human weight (ie 22.70 g of
UNCP) daily (equivalent to 9 teaspoonful daily) [40, 41].
For UNCP, the percentage RDA values for chromium
for men and women is 3750 and 5250 % respectively
while %RDA for copper corresponds to 103.6 % in
both sexes [27, 28].
The high content of Cu2+ should be of concern espe-
cially at high doses since copper has been shown to play
a role in the pathogenesis of Wilson’s syndrome and
liver damage. Besides other studies have shown adverse
effects of high copper intake like dyslipidemia and renal
dysfunction especially among diabetics [42, 43] where it
also induced oxidative stress and diminished antioxidant
enzymes. This effect on renal function however needs
further investigation.
Urea levels significantly reduced in the 1500 mg/kg
group as compared to the coartem® only group. Creatin-
ine levels decreased in all the groups compared to the
control group. These observed effects can be attributed
to the antioxidant and nephroprotective effects of cocoa
[41]. The animals that received only the 75 mg/kg coar-
tem® group showed high levels of renal damage
Fig. 10 Changes in Creatinine levels (μmol/L) during a 14- day
administration of UNCP in male guinea pigs followed by a 3-day
coartem® administration. Values are expressed as mean ± SEM, n =6.
The differences among the mean were analyzed using one-way ANOVA
followed by Neuman-keul’s post hoc analysis. Vertical bars represent
Mean ± SEM of creatinine count on various animal groupings. Values
are considered significant when *P< 0.05)
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evidenced by the histopathological observations (Fig. 12b)
and this could be due to the absence of any protective
effect from the flavonoids in cocoa since they didn’t re-
ceive any UNCP administration. Animals that received
900 mg/kg UNCP showed significant renoprotective
effect in the histopathological analysis (Fig. 12a). A reno-
protective effect has also been reported where the activa-
tion of adenosine monophosphate-activated protein
kinase (AMPK) by cocoa enriched polyphenols followed
by reduction in NOX4/TGFβ-1 signaling may have a
therapeutic potential in diabetic nephropathy in experi-
mental diabetes mellitus [44–46].
Previous studies have shown increases in nitric oxide
levels during UNCP administration in guinea pigs (un-
published data). Nitric oxide (NO) has been found to
have renoprotective and cardioprotective effects. Thus,
NO is likely to be among the mechanisms for cocoa’s pro-
tective effects. NO oxide increases associated with UNCP
could be attributed to its flavonoid content [46, 47, 48].
Cocoa and flavonoid rich chocolate as well as cocoa drinks
have been found to increase nitric oxide level [21, 22].
These protective effects of UNCP may be due to in-
creased availability of antioxidants in plasma, increased
plasma levels of nitric oxide mediated by constituents of
cocoa such as flavonoids cocoa butter and polyphenols
and also the presence of these macro and micro ele-
ments in UNCP [44, 46–49]. The above study has shown
that UNCP has cardioprotective and nephroprotective
potential against A/L induced toxicity. Thus the simul-
taneous consumption of UNCP and A/L is not likely to
be deleterious to the heart and kidney but rather advan-
tageous. It would be interesting to conduct a similar
study, using malarious guinea-pigs to look at the extent
and level of parasitaemia in individual test drug adminis-
tration and during A/L and UNCP combination.
Conclusion
For UNCP, the percentage RDA values for chromium for
men and women is 3750 % and 5250 % respectively
while %RDA for copper corresponds to 103.6 % in both
sexes. Also, UNCP has cardioprotective and renoprotec-
tive potential during high dose A/L administration and
Fig. 11 A representative section of the cardiac muscle (a) that retained the normal branching of myocardial cells characteristic of normal
myocardial tissue histology (VCG and 900 mg/kg UNCP) (b) that showed very little in terms of deterioration or inflammation (1500 mg/kg
UNCP) (c) with evidence of section of the heart with ongoing tissue necrosis in a section of myocardial tissue of one of the animals that
received 300 mg/kg UNCP. The region appeared intensely stained indicating the presence of dead cells (arrowed) (d) showing patchy
areas of congestion, oedema, extensive nuclear and tissue degeneration leading to loss of microstructure of myocardial tissues (arrowed).
This was observed with animals that received 3 day A/L (75 mg/kg) only (NCG)
Table 1 Comparison of literature and calculated percentage RDA of some selected elements [29]
Element MEAN LEVELS (mg/4g UNCP) WHO RDA (men) WHO RDA (women) % RDA of UNCP (men) % RDA of UNCP (women)
Na 2.4666 ± 0.00 1500 mg 1500 mg 0.51 0.51
Mg 33.0133 ± 0.02 420 mg 320 mg 24.60 32.30
P 64.3866 ± 0.00 700 mg 700 mg 28.70 28.70
Cl 2.3616 ± 0.00 2300 mg 2300 mg 0.32 0.32
K 149.0667 ± 0.03 4700 mg 4700 mg 10.00 10.00
Ca 11.0146 ± 0.00 1000 mg 1000 mg 3.40 3.40
Mn 0.4093 ± 0.00 2.3 mg 1.8 mg 56.50 72.20
Fe 1.0309 ± 0.00 8.0 mg 18 mg 40.25 17.90
Cr 0.4200 ± 17.44 35 μg 25 μg 3750.00 5250.00
Cu 0.2984 ± 1.71 900 μg 900 μg 103.60 103.60
Zn 0.4086 ± 0.74 11 mg 8 mg 11.60 16.00
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thus simultaneous ingestion of A/L and UNCP may
not be detrimental to the heart and kidney. However,
regular consumption of large quantities of UNCP
could pose health problems due to the high elemental
content of copper.
Limitation
Other cardiac and renal markers could also have been
investigated. Animals infected with specific malaria para-
sites could have been used as a source of comparison.
Other species of animals could also be used to conduct
this research.
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Fig. 12 A representative section of the kidney showing (a) Normal nuclear lining and uncongested tubular lumen with normal glomeruli observed in
the VCG and animals that received UNCP (300, 900 and 1500 mg.kg) (b) kidney damages observed in animals that received NCG ie A/L 75 mg/kg
for 3 days (and one animal that received 1500 mg/kg UNCP). Note the severe red blood cells infiltration, congested glomeruli and tubular
lining anucleasis (note left picture)
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